Endocannabinoid System Research: First-Episode Psychosis
First-episode psychosis predictors include substance use and aggressive behavior, which are linked to criminal legal involvement. Understanding these predictors helps clinicians implement early interventions. The endocannabinoid system research supports…
Clinical Research on Endocannabinoid System and Psychosis
Endocannabinoid system psychosis research provides critical clinical evidence for understanding first episode psychosis. This research highlights correlations between symptom severity and substance use. Early intervention informed by this research may…
Insights into Cannabis-Induced Psychosis and Schizophrenia Progression
Cannabis-induced psychosis schizophrenia progression insights reveal that a significant number of patients may develop schizophrenia spectrum disorders over time. Early identification of cannabis-induced psychosis is crucial for monitoring and…
Endocannabinoid System Clinical Research: REAL 2.0 Findings
The REAL 2.0 study highlights endocannabinoid system adolescent mental health factors influencing adult outcomes. Early body image and disordered eating patterns are key indicators. This research supports early screening for mental health and substance…